![Pharmacodynamics of bardoxolone methyl. A, levels of NF- k B, cyclin... | Download Scientific Diagram Pharmacodynamics of bardoxolone methyl. A, levels of NF- k B, cyclin... | Download Scientific Diagram](https://www.researchgate.net/publication/225063734/figure/fig1/AS:299277558534149@1448364738525/Pharmacodynamics-of-bardoxolone-methyl-A-levels-of-NF-k-B-cyclin-D1-and-TUNEL.png)
Pharmacodynamics of bardoxolone methyl. A, levels of NF- k B, cyclin... | Download Scientific Diagram
![Bardoxolone methyl: drug development for diabetic kidney disease | Clinical and Experimental Nephrology Bardoxolone methyl: drug development for diabetic kidney disease | Clinical and Experimental Nephrology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10157-020-01917-5/MediaObjects/10157_2020_1917_Fig5_HTML.png)
Bardoxolone methyl: drug development for diabetic kidney disease | Clinical and Experimental Nephrology
![Figure 2 from Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties | Semantic Scholar Figure 2 from Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/10f0dd7b5611c76094720eb63c91db11d943e9a4/4-Figure2-1.png)
Figure 2 from Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties | Semantic Scholar
![APExBIO - Bardoxolone methyl|IKK inhibitor, potent antioxidant inflammation modulator|CAS# 218600-53-4 APExBIO - Bardoxolone methyl|IKK inhibitor, potent antioxidant inflammation modulator|CAS# 218600-53-4](http://www.apexbt.com/pub/media/prod_images/a/3/a3221.png)
APExBIO - Bardoxolone methyl|IKK inhibitor, potent antioxidant inflammation modulator|CAS# 218600-53-4
Design and Synthesis of Irreversible Analogues of Bardoxolone Methyl for the Identification of Pharmacologically Relevant Targets and Interaction Sites | Journal of Medicinal Chemistry
![Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease - ScienceDirect Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0085253819305034-fx1.jpg)
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease - ScienceDirect
![IJMS | Free Full-Text | Insights into the Molecular Mechanisms of NRF2 in Kidney Injury and Diseases IJMS | Free Full-Text | Insights into the Molecular Mechanisms of NRF2 in Kidney Injury and Diseases](https://pub.mdpi-res.com/ijms/ijms-24-06053/article_deploy/html/images/ijms-24-06053-g001.png?1679566143)
IJMS | Free Full-Text | Insights into the Molecular Mechanisms of NRF2 in Kidney Injury and Diseases
Synthesis, Biological Evaluation, and Molecular Docking Study of 3-Amino and 3-Hydroxy-seco A Derivatives of α-Amyrin and 3-Epilupeol as Inhibitors of COX-2 Activity and NF-kB Activation | Journal of Natural Products
![Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease | Signal Transduction and Targeted Therapy Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-021-00628-x/MediaObjects/41392_2021_628_Fig1_HTML.png)
Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease | Signal Transduction and Targeted Therapy
![Frontiers | Bardoxolone Methyl Ameliorates Compression-Induced Oxidative Stress Damage of Nucleus Pulposus Cells and Intervertebral Disc Degeneration Ex Vivo Frontiers | Bardoxolone Methyl Ameliorates Compression-Induced Oxidative Stress Damage of Nucleus Pulposus Cells and Intervertebral Disc Degeneration Ex Vivo](https://www.frontiersin.org/files/Articles/814040/fbioe-09-814040-HTML/image_m/fbioe-09-814040-g005.jpg)